📰 Protein Sciences News
Page 12 - Protein Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Protein Sciences. Real-time updates on events, politics, business and more.
May 2, 2023
Geneva Capital Management LLC grew its position in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 297.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,059,500 shares of the biotechnology company’s stock after purchasing an additional 793,107 shares during the quarter. Bio-Techne […]
May 1, 2023
Pfizer is planning a $470-million expansion of its Vaccine Research and Development facilities in Pearl River, NY.
April 30, 2023
S&CO Inc. increased its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 26,080 shares of the biotechnology company’s stock after acquiring an additional 19,560 shares during the quarter. S&CO Inc.’s holdings in Bio-Techne […]
April 30, 2023
Lmcg Investments LLC raised its position in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,069 shares of the biotechnology company’s stock after buying an additional 11,309 shares during the quarter. Lmcg Investments […]
April 29, 2023
StockNews.com upgraded shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a hold rating to a buy rating in a research report report published on Wednesday. TECH has been the topic of several other research reports. Wells Fargo & Company upgraded shares of Bio-Techne from an underweight rating to an equal weight rating and set a […]
April 29, 2023
Bio-Techne Co. (NASDAQ:TECH – Get Rating) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 3,750,000 shares, a growth of 55.6% from the March 31st total of 2,410,000 shares. Based on an average daily trading volume, of 1,040,000 shares, the short-interest ratio is […]
April 27, 2023
StockNews.com upgraded shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a hold rating to a buy rating in a research note issued to investors on Wednesday. Several other research analysts have also recently weighed in on TECH. Wells Fargo & Company raised shares of Bio-Techne from an underweight rating to an equal weight rating and […]
April 27, 2023
Cwm LLC lifted its stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 513.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,044 shares of the biotechnology company’s stock after buying an additional 1,711 shares during the quarter. Cwm LLC’s holdings in Bio-Techne were […]
April 26, 2023
Pfizer is planning a $470-million expansion of its Vaccine Research and Development facilities in Pearl River, NY.
April 25, 2023
Securian Asset Management Inc. raised its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 285.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,016 shares of the biotechnology company’s stock after buying an additional 9,636 […]